Apellis Pharmaceuticals
Global biopharma company leveraging courageous science, creativity, and compassion to deliver life-changing therapies.
769 employees · est. 2008 · Waltham, United States
Arvinas
Leading the way in targeted protein degradation therapeutics
305 employees · est. 2013 · New Haven, United States
Apellis Pharmaceuticals is the older company (2008 vs 2013); Apellis Pharmaceuticals is the larger of the two.
1 signal in the last 90 days
Side-by-Side Comparison
| Metric | Apellis Pharmaceuticals | Arvinas |
|---|---|---|
| Founded | ||
| Founded | 2008 older | 2013 |
| Headquarters | ||
| Headquarters | Waltham, United States | New Haven, United States |
| Employees | ||
| Employees | 769 larger | 305 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Post Ipo Debt | Unknown |
| Total Funding | ||
| Total Funding | $643.53M | $585.85M |
| Funding Rounds | ||
| Funding Rounds | 11 | 6 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Biopharma, Therapeutics, Drug Delivery, Chronic Inflammatory Diseases, Asthma, Chronic Obstructive Pulmonary Disease, Complement Cascade, Ophthalmology, Nephrology, Hematology, Neurology, Paroxysmal Nocturnal Hemoglobinuria, Gene Therapy, Amyotrophic Lateral Sclerosis | Biopharmaceutical, Protein Degradation, Therapeutics, Clinical-stage, Disease Treatment, PROTAC® Discovery Engine Platform, Proteolysis Targeting Chimeras, Metastatic Castrate-resistant Prostate Cancer, Locally Advanced Breast Cancer, Metastatic ER+/HER2- Breast Cancer, Drug Discovery, Autoimmune Diseases, Rare Diseases, Cancer Therapy, Preclinical Pipeline |
| Website | ||
| Website | apellis.com | arvinas.com |
About Apellis Pharmaceuticals
Apellis Pharmaceuticals is a biopharma company harnessing bold science, creativity, and compassion to bring life-changing therapies to patients worldwide. Founded in 2008, Apellis focuses on developing innovative treatments for various debilitating diseases by targeting complement, a key component o...
About Arvinas
Arvinas is a clinical-stage biopharmaceutical company founded in 2013 and headquartered in the United States. The company is committed to developing targeted protein degradation therapeutics with the aim of improving the lives of patients suffering from debilitating and life-threatening diseases. Th...
We will tell you when either one moves
BounceWatch watches Apellis Pharmaceuticals and Arvinas for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Apellis Pharmaceutical... and Arvinas — by email.
Frequently Asked Questions
Compare Apellis Pharmaceuticals with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Apellis Pharmaceuticals on 12 Sep 2024, and Arvinas on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.